Treatment Algorithm for Hepatocellular Carcinoma
Tanios S. Bekaii-Saab, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment practices for patients with hepatocellular carcinoma.
Tanios S. Bekaii-Saab, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment practices for patients with hepatocellular carcinoma.
Phase 2 data support the use of fuzuloparib with or without apatinib in HER2-negative metastatic breast cancer harboring BRCA1/2 germline mutations.
AbstractBackgroundCardiovascular disease (CVD) is the leading cause of death worldwide, but prevalence estimates in former professional athletes are limited.ObjectivesHUDDLE (Heart Health: Understa…
This Breakout, held at Transcatheter Interventions Online 2024, discovers the concept of sensor-guided TAVI interventions using a dedicated LV-pacing guidewire designed to deliver
The 8th Cutter Symposium focused on one of the major challenges of obtaining accurate results in nutrition studies—the role of hidden, so-called confounding factors in…
The fellows discussed how to choose a career path, what makes a good mentor, and more.
The event was hosted by James Spratt, St George’s University Hospital NHS Trust, London, UK with and Emanuele Barbato Sant Andrea Hospital, Rome, IT in…
A new study recorded data on the type of treatment received in each line of therapy for advanced urothelial carcinoma, as well as the attrition…
Patients who received Orca-T had “superior” all-grade chronic GVHD-free survival after allogeneic HSCT compared with those recieved PTCy.
The Oncology Brothers are joined by Nina Sanford, MD; Jeffrey M. Ryckman, MD; and Harris Chengazi, MD, to discuss the treatment of patients with hepatocellular…